brolucizumab

It is used in adults to treat eye disorders caused by the formation of abnormal blood vessels under the macula, such as age-related neovascular macular degeneration (wet AMD) and diabetic macular edema (DME). It may help slow the disease and maintain or improve vision.

Form: solution for injection in pre-filled syringe

ATC: S01LA06

Manufacturer: NOVARTIS EUROPHARM LIMITED